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Background and aim: Common chickweed (Stellaria media) tea has traditionally been applied for treat-
ment of various metabolic diseases including diabetes in folk medicine; however, experimental evidence
to support this practice is lacking. Therefore, we aimed to assess the effect of Stellaria media tea on
glucose homeostasis and cardiac performance in a rat model of diabetes.
Experimental procedure: Hot water extract of Stellaria media herb were analyzed and used in this study,
where diabetes was induced by fructose-enriched diet supplemented with a single injection of strep-
tozotocin. Half of the animals received Stellaria media tea (100 mg/kg) by oral gavage. At the end of the
20-week experimental period, blood samples were collected and isolated working heart perfusions were
performed.
Results and conclusion: Compared to the animals receiving standard chow, serum fasting glucose level
was increased and glucose tolerance was diminished in diabetic rats. Stellaria media tea did not affect
significantly fasting hyperglycemia and glucose intolerance; however, it attenuated diabetes-induced
deterioration of cardiac output and cardiac work. Analysis of the chemical composition of Stellaria me-
dia tea suggested the presence of rutin and various apigenin glycosides which have been reported to
alleviate diabetic cardiomyopathy. Moreover, Stellaria media prevented diabetes-induced increase in
cardiac STAT3 phosphorylation. We demonstrated for the first time that Stellaria media tea may bene-
ficially affect cardiac dysfunction induced by diabetes without improvement of glucose homeostasis.bert Szent-Gy€orgyi Medical
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AUC area under the curve
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HbA1c haemoglobin A1cRutin and/or apigenin glycosides as well as modulation of STAT3 signaling may be implicated in the
protection of Stellaria media tea against diabetic cardiomyopathy.
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HDL high-density lipoprotein cholesterol
HPLC high performance liquid chromatography
LC-MS/MS liquid chromatography-tandem mass spectrometry
LDH lactate dehydrogenase
LVDP left ventricular developed pressure
LVEDP left ventricular end-diastolic pressure
OGTT oral glucose tolerance test
ORAC oxygen radical absorbance capacity
QE quercetin equivalent
Stellaria m. Stellaria media
STAT3 signal transducer and activator of transcription 3
STZ streptozotocin
UPLC ultra-performance liquid chromatography1. Introduction
Diabetes is a common metabolic disease characterized by
elevated blood glucose level and impaired glucose tolerance. The
prevalence of diabetes for adults was approximately 171 million
patients worldwide in 2000 and according to predictions, this
number is expected to be doubled by 2030.1 Due to the continu-
ously increasing trend in diabetes morbidity, investigation of
harmful consequences of the disease and potential therapeutic
interventions is a relevant current research area.1 In the absence of
proper therapy diabetes may lead to development of various
complications including cardiomyopathy, cataract, kidney failure,
as well as neuronal damage. Diabetic cardiomyopathy is charac-
terized by diastolic and/or systolic dysfunction which can lead to
heart failure without the presence of classic risk factors such as
dyslipidaemia, hypertension, or coronary artery disease.2,3
Nowadays, medicinal plants are gaining popularity in preven-
tion and treatment of various diseases including diabetes. There are
some herbs with a well-described and scientifically proven anti-
hyperglycaemic properties, for instance aqueous leaf extract of
stinging nettle (Urtica dioica)4,5 or powdered fenugreek seeds
(Trigonella foenum graecum).6,7 In folk medicine, Stellaria media is
believed to be a remedy to lose weight8 and it is suggested to be
used for its believed beneficial effects on blood lipid profile.9 Ac-
cording to a popular Hungarian traditional healer, Stellaria media
tea improves general metabolism, lowers blood glucose level,
making it an adjuvant therapy for diabetic patients.10 Moreover,
consumption of chickweed tea for lowering blood glucose level is
recommended by somewebsites dealing with medicinal plants and
health issues.11,12 Although, an animal experiment proposed an
anti-hyperglycaemic effect of intraperitoneally administered alco-
holic Stellaria media extract,13 the clinical translation of this design
is limited since Stellaria media is mostly consumed as tea. Never-
theless, potential effects of Stellaria media tea on diabetes-induced
cardiac dysfunction has never been investigated.
Taken together, there is no firm experimental or clinical evi-
dence supporting the anti-diabetic effect of Stellaria media tea.
Therefore, the aim of the present study was to investigate the2
potential therapeutic efficacy of Stellaria media tea on the severity
of diabetes and on harmful cardiac consequences induced by
diabetes.
2. Materials and methods
2.1. Animals
The experiment conforms to the Guide for the Care and Use of
Laboratory Animals published by the U.S. National Institutes of
Health [National Institutes of Health publication 85e23, revised
1996] and the regulations of the Hungarian Act No. XXVIII of the
year 1998 on protection and care of animals were strictly followed.
The studywas approved by the local animal ethics committee of the
University of Szeged (XV.1181/2013).
Altogether 30 adult (9-week old) male Wistar rats were used in
this study (purchased from Charles River Laboratories, G€ottingen,
Germany), weighing 292e420 g at the onset of the experiments.
Rats were kept under standard climatic conditions (22 ± 2 C room
temperature, 12h light/dark cycles) in pairs in individually venti-
lated cages (Sealsafe IVC system, Buguggiate, Italy) and had ad
libitum access to tap water and rat chow.
2.2. Experimental setup
After one week of acclimatization, the rats were randomized
into three groups: Control, Diabetes, Diabetes þ Stellaria media
treatment. Rats in the control group (n ¼ 10) received standard
laboratory rat chow for 20 weeks. The other 20 rats were fed a
special fructose-enriched diet, i.e. a standard laboratory rat chow
(Innovo Ltd., Isaszeg, Hungary) supplemented with 60% (w/w)
fructose (Floravita Ltd., Soltvadkert, Hungary) for 20 weeks14 and
were treated with a low-dose streptozotocin (STZ) injection
(20 mg/kg body weight, ip.) on the 17th week. Combination of
fructose-enriched diet/drinking water and low-dose STZ treatment
has been reported to be an alternative approach to achieve exper-
imental type 2 diabetes15e17 (Fig. 1A). In order to prevent STZ-
induced hypoglycaemia, drinking water containing 10% glucose
Fig. 1. Experimental protocol: rats were divided into Control, Diabetes and Diabetes þ Stellaria media groups receiving either a standard chow or a chow supplemented with 60%
fructose, respectively, for 20 weeks (A). Fasting blood glucose measurement was performed every four weeks until week 16. Oral glucose tolerance test (OGTT) was performed on
week 12, 16 and 19. At week 17, rats in the Diabetes and Diabetes þ Stellaria media groups were injected with a low-dose streptozotocin (20 mg/kg body weight) intraperitoneally.
Fasting blood glucose was measured on week 18 and 19 to monitor the effect of streptozotocin injection. On week 20, the animals were anaesthetised and sacrificed. Blood samples
were collected from the abdominal aorta, hearts were isolated and subjected to working heart perfusion according to Neely (A). Body weight (B) and weight gain (C) during 20
weeks in the Control group (circles), Diabetes group (squares) and Diabetes þ Stellaria media group (triangles). Results are means ± SEM (n ¼ 8e10), analyzed by repeated measures
two-way ANOVA or one-way ANOVA with Holm-Sidak post hoc test,*p < 0.05 Diabetes vs. Control.
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receiving fructose-enriched chow was further supplemented with
Stellaria media tea administered by oral gavage (Diabetesþ Stellaria
media) in order to examine the potential effects of Stellaria media
tea on the glucose homeostasis and cardiac function, while the
other rats received equal amount of distilled water. One animal in
the Control group and two animals in the Diabetes group were
excluded due to technical problems occurring during the
treatments.
Fasting blood glucose level measurements were performed
every 4 weeks, accompanied by oral glucose tolerance (OGTT) tests
at weeks 12, 16 and 19 (Fig. 1A). On the 20th week, rats were
anaesthetised with sodium pentobarbital (Euthasol, 50 mg/kg body
weight, ip., Produlab Pharma b.v., Raamsdonksveer, The
Netherlands), the abdominal cavity was opened, and blood samples
were taken from the abdominal aorta. Collected blood was allowed
to clot and was centrifuged (2000 g, 20 min, 4 C), then serumwas
separated for analysis of various serum parameters. Then the rats
were given 500 U kg1 heparin intravenously into the vena cava
inferior. Isolated hearts were subjected to working heart perfusion
according to Neely in order to evaluate cardiac function.2.3. Preparation of Stellaria media tea
Stellaria media was harvested in Algy}o (Hungary) by ‘Ezerjof}u’
Association in 2017. Voucher specimen (No: 882) was deposited in
Herbarium of the University of Szeged, Faculty of Pharmacy,
Department of Pharmacognosy. The drug was dried and stored at
room temperature. The dried and grounded drug was extracted
with boiling water (1:10 w/v ratio) for 15 min by ultrasonication.
The highly dense extract was separated from solid particles by3
mechanical press. The aqueous extract was dry-freezed. 1.5 g of
dark-green lyophilized powder was equal to 10 g of dried drug. The
lyophilized powder was dissolved in distilled water to achieve a
final concentration of 100 mg/ml. The extract and the vehicle
(distilled water) were then stored at 4 C andwere brought to room
temperature before administration.2.4. Stellaria media administration
Rats in the Diabetes þ Stellaria media group received 100 mg/kg
body weight Stellaria media tea with traditional oral gavage tech-
nique once a day since the onset of the experiment. The Control and
Diabetes groups received equal amount of distilled water. The
treatment was carried out at the same 2-h time range every day to
minimalize the possible influence of circadian rhythm. The 100mg/
kg body weight dose of Stellaria media tea was considered as equal
to the recommended human daily dose, that is 2 cups of tea, pre-
pared with 3 g dried herb per cup, calculated according to Nair and
Jacob considering the differences in body surface area.182.5. Working heart perfusion
Cardiac performance and function was assessed in isolated
Neely working hearts, as described earlier.19,20 Cardiac functional
parameters including heart rate, coronary flow, aortic flow, cardiac
output, left ventricular developed pressure (LVDP) and its first
derivatives (dp/dt max and dp/dt min), and left ventricular end-
diastolic pressure (LVEDP) were measured. Cardiac work was
calculated by multiplying cardiac output and maximum pressure.
For more information, see Supplementary Material.
Fig. 2. Fasting blood glucose levels (A) and area under the curve (AUC) (B) values of oral glucose tolerance tests (OGTT) measurements. Results are means ± SEM (n ¼ 8e10),
analyzed by one-way ANOVA followed by Holm-Sidak post hoc test,*p < 0.05 vs. Control, #p < 0.05 vs. Diabetes.
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Several serum parameters describing pancreas, liver and kidney
function, cardiac markers, lipid panel and electrolytes were
analyzed by Roche Cobas 8000 Analyzer System using enzymatic
colorimetric assays from Roche (Mannheim, Germany). For further
details, please see Supplementary Material. Haemoglobin A1c
(HbA1c) levels were analyzed by DCA Vantage Analyzer System
(Siemens) provided by Diagnosticum Ltd. (Budapest, Hungary).
2.7. Measurement of serum insulin levels
Serum insulin levels were determined by enzyme-linked
immunosorbent assay (ELISA) technique (Mercodia, Ultrasensitive
Rat Insulin ELISA) according to the instructions of the
manufacturer.21
2.8. Total flavonoid content and screening for flavonoids
The total flavonoid content was determined as quercetin
equivalent (QE) using the aluminum chloride colorimetric method.
The lyophilizate powder was dissolved in methanol to get a solu-
tionwith a concentration of 1mg/mL. For calibration curve 5,10, 25,
50 mg/mL methanolic solutions of quercetin were prepared. As re-
agent, 2% aluminum chloride methanolic solution was used. Reac-
tion mixtures were prepared by mixing 2 mL of solution and 2 mL
of aluminum chloride, respectively. After 60 min of incubation at
room temperature, the absorbance was measured against blank by
applying UV-VIS spectrophotometer (Helios b ThermoSpectronic)
at 420 nm. The total flavonoid concentrationwas calculated using a
calibration plot (R2 ¼ 0.9999). The measurements were carried out
in triplicate.
The flavonoid content of the lyophilized Stellaria media aqueous
extract was screened by ultra-performance liquid chromatography
(UPLC). For this experiment 1 mg/mL methanolic solution was
prepared from the lyophilizate. The presence of ubiquitous flavo-
noids in plants, namely apigenin, apigenin-7-glucoside, kaemp-
ferol, luteolin, quercetin, and rutin was screened by UPLC.
Experiments were carried out on a Shimadzu Nexera X2 UHPLC
liquid chromatography system. For more information, see Supple-
mentary Material.
2.9. Liquid chromatography-tandem mass spectrometry analysis
In order to gain more information about the chemical compo-
sition, the aqueous extract was filtered through a 0.22 mm mem-
brane filter and diluted tenfold with 0.1% formic acid and analyzed4
by data-dependent liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) analysis using a Waters MClass nanoUPLC
system online coupled to an Orbitrap Fusion Lumos Tribrid mass
spectrometer. MS2 data were subjected to a spectral library search
against the MzCloud database using the Compound Discovery
software. For more information, see Supplementary Material.
2.10. Measurement of the antioxidant activity
The measurement of 2,2-diphenyl-1-picryl-hydrazyl-hydrate
(DPPH) free radical scavenging activity was carried out according to
the method of Fukumoto et al. with some modifications.22 The
Oxygen Radical Absorbance Capacity (ORAC) assay was carried out
according to the method of Mielnik et al.23 For further details,
please see Supplementary Material.
2.11. Western blot analysis
Phosphorylation of key proteins of well-known cardioprotective
signaling pathways, signal transducer and activator of transcription
3 (STAT3), protein kinase B (Akt) and extracellular signal-regulated
kinase (Erk) proteins and activation of apoptosis-related Bax and
Bcl-XL proteins and GLUT4 glucose transporter were detected by
Western blot technique as described earlier.24 For more informa-
tion, see Supplementary Material.
2.12. Statistical analysis
All values are presented as mean ± SEM. Repeated measures
two-way ANOVA was applied for analysis of time-dependent body
weight change. One-way ANOVA was used to determine the dif-
ferences among the three experimental groups and p < 0.05 was
accepted as statistically significant difference, using Holm-Sidak
post hoc test. In the analysis of the working heart perfusion and
Western blot results, those data which were out of mean ± 2SD
range were excluded in order to minimalize the effect of
extremities.
3. Results
3.1. Time course of body weight, fasting blood glucose and OGTT
values
Body weight was measured every 3 days in order to calculate
Stellaria media tea dosage and to monitor weight gain. It showed a
continuous increase from 356 ± 7 g at the onset of the experiment
to 482 ± 16 g at week 20 in the Control group fed with standard
Fig. 3. Parameters representing pancreatic function at week 20: fasting blood glucose at termination (A), HbA1c levels (B), serum insulin levels (C), pancreas weight (D), enzyme
activities of a-amylase (E) and lipase (F). Results are means ± SEM (n ¼ 8e10 except for serum insulin measurement where n ¼ 6e8), analyzed by one-way ANOVA followed by
Holm-Sidak post hoc test,*p < 0.05 vs. Control.
Table 1
Serum parameters representing liver and kidney function, cardiac markers, lipid
panel and electrolytes.




ALAT (U/L) 34.7 ± 2.0 23.9 ± 2.2* 29.1 ± 2.5 <0.05
ASAT (U/L) 65.1 ± 2.5 50.4 ± 1.8* 55.6 ± 1.9* <0.05
ALP (U/L) 46.9 ± 1.9 86.5 ± 12.7* 101.4 ± 10.4* <0.05
Albumin (g/L) 40.8 ± 0.8 41.8 ± 0.6 42.0 ± 0.4 ns
Total protein (g/L) 54.0 ± 1.5 55.9 ± 0.4 57.3 ± 0.7* <0.05
Kidney function:
Urea (mmol/L) 6.3 ± 0.3 3.8 ± 0.7* 3.8 ± 0.3* <0.05
Creatinine (mmol/L) 32.1 ± 1.3 35.3 ± 1.8 35.2 ± 1.6 ns
Cardiac markers:
CK (U/L) 276.9 ± 25.7 235.1 ± 19.4 289.7 ± 29.8 ns
CK-MB (U/L) 438.6 ± 29.1 433.8 ± 37.9 524.8 ± 55.6 ns
LDH (U/L) 281.7 ± 26.0 298.4 ± 23.3 359.3 ± 42.9 ns
Lipid panel:
Cholesterol (mmol/L) 1.58 ± 0.05 1.74 ± 0.16 1.78 ± 0.11 ns
HDL-Cholesterol (mmol/L) 0.95 ± 0.04 1.03 ± 0.08 1.08 ± 0.10 ns
Electrolytes:
Sodium (mmol/L) 142.1 ± 0.9 141.5 ± 0.9 140.2 ± 1.1 ns
Potassium (mmol/L) 4.8 ± 0.1 5.1 ± 0.1 5.1 ± 0.2 ns
Chloride (mmol/L) 101.9 ± 0.5 101.3 ± 0.8 101.0 ± 0.5 ns
Results are means ± SEM (n ¼ 8e10), analyzed by one-way ANOVA followed by
Holm-Sidak post hoc test,*p < 0.05 vs. Control. ALP alkaline phosphatase, ALAT
alanine aminotransferase, ASAT aspartate aminotransferase, CK creatine kinase, CK-
MB creatine kinase e myocardial band, HDL high-density lipoprotein cholesterol,
LDH lactate dehydrogenase, ns non-significant.
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enriched diet plus STZ injection reduced body weight increase in
the last 6 weeks in the Diabetes group, however, this effect was not
significant in the Diabetes þ Stellaria media group (Fig. 1B). Weight
gain during the feeding protocol was significantly lower in the
Diabetes group compared to the Control group (Fig. 1C). Similarly,
there was a tendency of decrease in the Diabetes þ Stellaria media
group compared to the controls; however, it did not reach the level
of statistical significance (Fig. 1C).
Fasting blood glucose levels weremeasured every 4 weeks since
the onset of the experiment, accompanied by OGTT at weeks 12, 16
and 19. In fasting blood glucose levels and glucose tolerance, there
was no significant difference among the three groups until week 16
(Fig. 2A and B). On the 17th week, the rats in the Diabetes and
Diabetes þ Stellaria media groups were injected with a low dose of
STZ injection (20 mg/kg body weight, ip.), while the Control group
was treated with equal amount of vehicle (citrate buffer). Following
the STZ injection a significant elevation in fasting blood glucose
levels could be observed in the Diabetes group compared to the
Control group, achieving an experimental diabetes state (Fig. 2A).
Although on week 18 the blood glucose elevation in the
Diabetes þ Stellaria media group was significantly lower compared
to the Diabetes group, this difference was faded away by week 19
(Fig. 2A). According to our OGTT results, there was a significant
elevation in the area under the curve (AUC) levels in the Diabetes
group compared to the Control group on week 19 (Fig. 2B) repre-
senting an impairment of glucose tolerance. Stellaria media treat-
ment did not affect glucose intolerance (Fig. 2B).5
Fig. 4. Cardiac function in isolated hearts subjected to working perfusion according to Neely: cardiac output (A), cardiac work (B), left ventricular end diastolic pressure (LVEDP) (C).
Results are means ± SEM (n ¼ 8e10), analyzed by one-way ANOVA followed by Holm-Sidak post hoc test,*p < 0.05 vs. Control, #p < 0.05 vs. Diabetes.
Table 2
Parameters measured by working heart perfusion according to Neely.
Control Diabetes Diabetes þ
Stellaria m.
p
Aortic flow (mL) 44.4 ± 2.6 27.3 ± 2.4* 34.4 ± 2.3* p < 0.05
Coronary flow (mL) 22.8 ± 0.7 21.8 ± 1.5 23.7 ± 1.0 ns
Max dp/dt (mmHg/s) 6323 ± 282 6260 ± 439 6431 ± 487 ns
Min dp/dt (mmHg/s) e 4520 ± 188 e 4512 ± 397 e 4496 ± 374 ns
Aortic diastolic pressure (mmHg) 37.6 ± 0.5 37.9 ± 0.8 37.8 ± 1.1 ns
Aortic systolic pressure (mmHg) 114.8 ± 2.5 110.4 ± 3.3 114.9 ± 3.1 ns
LVDP (mmHg) 136.2 ± 4.6 130.0 ± 4.5 131.3 ± 5.2 ns
Heart rate (1/min) 240 ± 10 211 ± 16 231 ± 11 ns
Results are means ± SEM (n ¼ 8e10), analyzed by one-way ANOVA with Holm-Sidak post hoc test,*p < 0.05 vs. Control. LVDP left ventricular developed pressure, ns non-
significant.
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pancreas
At the end of the 20-week experiment, elevated fasting blood
glucose, non-significantly increased HbA1c (3.6 ± 0.1% in Control
and 4.3 ± 0.5% in Diabetes, respectively) and serum insulin levels
decreased by approximately 20% indicated impaired endocrine
pancreatic function (Fig. 3AeC) in the Diabetes group. Stellaria
media tea failed to improve these parameters (Fig. 3AeC), and
HbA1c was 4.6 ± 0.4% in this group. Pancreas weight was signifi-
cantly lower in the Diabetes group compared to the Control group
(Fig. 3D), showing that there might have been pancreatic damage
due to the fructose-enriched diet plus STZ injection. Stellaria media
did not affect this alteration. The serum activity of a-amylase was
significantly elevated both in the Diabetes and Diabetes þ Stellaria
media groups (Fig. 3E), while there was no difference among the
three groups in the activity of lipase enzyme (Fig. 3F).3.3. Serum parameters of liver and kidney function, cardiac
markers, lipid panel and electrolytes
At termination of the animals, blood samples were collected
from the abdominal aorta and several serum parameters were
measured. Markers of liver function, such as alanine aminotrans-
ferase (ALAT), aspartate aminotransferase (ASAT) and alkaline
phosphatase (ALP) enzyme activities, as well as albumin and total
protein concentrations were measured. Diabetes caused a signifi-
cant decrease in ALAT and ASAT enzyme activities and an elevation
in ALP enzyme activity without affecting albumin or total protein
concentration indicating lack of considerable liver damage
(Table 1). Serum parameters describing kidney function were also
measured. Urea levels were significantly lower in the Diabetes
group compared to the Control group (Table 1). There was no dif-
ference in the creatinine levels. Stellaria media tea did not affect
liver and kidney function compared to the Diabetes group (Table 1).
There was no significant difference among the three groups in
creatine kinase (CK), Creatine kinase e myocardial band (CK-MB)6
and lactate dehydrogenase (LDH) activities suggesting the lack of
significant cellular injury in the heart and other tissues (Table 1).
Cholesterol, high-density lipoprotein (HDL) cholesterol, as well as
relevant electrolytes, such as sodium, potassium and chloride levels
were not changed significantly among the groups (Table 1).
3.4. Ex vivo working heart perfusion
Cardiac dysfunction is a frequent consequence of diabetes,
therefore we assessed cardiac performance in hearts subjected to
working heart perfusion. Aortic flow, cardiac output and cardiac
work, reflecting systolic heart function, were significantly impaired
in the Diabetes group compared to the Control group (Fig. 4A and B,
Table 2), indicating diabetic adverse effects on the heart. Stellaria
media treatment significantly improved cardiac output and cardiac
work suggesting that Stellaria media tea may have beneficial effects
on the heart in a diabetic state (Fig. 4A and B). The diastolic function
of the hearts was assessed by measurements of LVEDP, which
inversely correlates with the function. LVEDP showed a tendency of
elevation in the Diabetes group compared to the Control group,
however, Stellaria media had no prominent effect on this parameter
(Fig. 4C). There were no significant alterations in the other analyzed
cardiac functional parameters among the three experimental
groups (Table 2).
3.5. Total flavonoid content, LC-MS/MS analysis and antioxidant
activity of Stellaria media tea
Flavonoids are active compounds in several medicinal herbs and
are related to anti-oxidative properties, therefore we analyzed the
flavonoid content of the Stellaria media tea. The total flavonoid
content determined by means of UV-VIS absorbance was
9.88 ± 0.10 mg quercetin equivalent/gram (QE/g). The flavonoid
screening by means of UPLC indicated rutin being a possible
component, based on comparison of its retention time and UV
spectrum with a reference standard.
In the LC-MS/MS analysis, several components have been
Fig. 5. Western blot analysis of phosphorylation of proteins: signal transducer and activator of transcription 3 (STAT3) (A), protein kinase B (Akt) (B), extracellular signal-regulated
kinase (Erk) (C), proapoptotic Bax (D), representative bands (E), antiapoptotic Bcl-XL (F). Results are means ± SEM (n ¼ 7), analyzed by one-way ANOVA followed by Fisher LSD post
hoc test,*p < 0.05 vs. Control, #p < 0.05 vs. Diabetes.
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components out of the ten most intense sample components,
which appeared to be various glycosylated apigenin-derivatives.
MS2 spectrum of m/z 595.1660 displayed reasonable resemblance
(MzCloud best match: 62.9) to MzCloud spectral library entries to
two isomeric compounds, 6-arabinosyl-8-galactosylapigenin (cor-
ymboside) and 6-b-D-glucopyranosyl-8-b-D-ribopyranosyla
pigenin (schaftoside), while MS2 spectrum ofm/z 595.1660 showed
good agreement (MzCloud best match: 82.8) with apigenin-6,8-di-
C-glucoside (vicenin). Two further components, m/z 757.2195 and
933.2657 showed similarity to MS2 data acquired on 200-O-a-L-
rhamnopyranosyl-isovitexin, a compound with the same apigenin
base structure. The molecular mass of these two components were
178.1 and 354.1 Da higher compared to the database entry. Six
further components (m/z 274.2737, 535.1448, 679.2974, 677.2817,
611.1608 and 381.0793) did not show any resemblance to MzCloud
entries indicating that these components were not included with
an MS2 spectrum in the spectral library.
Moreover, the lyophilized powder was evaluated for antioxidant7
activity using DPPH and ORAC assays. The lyophilized aqueous
extract of Stellaria media exerted low direct antioxidant capacity in
both assays: EC50 168.30 ± 11.06 mg/L in the DPPH assay and
0.97 ± 0.16 Trolox Equivalent mmol/g in the ORAC study.
3.6. Cardiac signaling pathways
Activation of STAT3 is proposed to play a role in diabetes-
induced cardiac dysfunction. The phosphorylation of STAT3 was
significantly elevated in the Diabetes group which was attenuated
by Stellaria media treatment (Fig. 5A), suggesting an association
with the beneficial cardiac effect of Stellaria media. There were no
significant differences among the three groups in the phosphory-
lation of Akt and Erk proteins (Fig. 5B and C). Since increased car-
diac apoptosis represents greater risk for the development of
diabetic cardiomyopathy,25e27 we examined apoptosis related
proteins in our study. Diabetes and Stellaria media treatment had no
effects on the proapoptotic Bax and antiapoptotic Bcl-XL proteins
(Fig. 5D and F). We also investigated GLUT4 transporter expression
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diabetes. Diabetes and Stellaria media treatment did not influence
GLUT4 protein expression (data not shown).
4. Discussion
In the present study, we tested the effects of Stellaria media tea
on the severity of diabetes as well as on diabetes-induced cardiac
consequences in an in vivo rat model. Based on our findings, Stel-
laria media tea appears to have beneficial effects on cardiac
dysfunction induced by diabetes, since the treatment ameliorated
the impaired cardiac output and cardiac work. However, this effect
seems to be independent of the modulation of diabetes severity as
the application of the tea treatment did not influence fasting
hyperglycaemia or glucose intolerance.
In folk medicine Stellaria media is consumed mainly as tea. To
the best of our knowledge, this is the first study investigating the
hot water extract of chickweed in the settings of diabetes. In our
study, Stellaria media was not effective in lowering blood glucose
level or improving glucose tolerance in diabetic rats. In the litera-
ture only one other study examined specifically the effect of Stel-
laria media on the severity of diabetes. Ethanolic leaf extract of
Stellaria media in a dose of 100e400 mg/kg/day administered by
intraperitoneal injection has been shown to attenuate hyper-
glycaemia in a 21-day alloxan-induced diabetic rat model.13 In that
study, Stellaria media treatment attenuated fasting blood glucose
levels, decreased haemoglobin A1c levels and inhibited pancreatic
a-amylase and b-glucosidase enzyme activities.13 There are also
some studies using various models where glucose homeostasis was
estimated among other metabolic parameters. For instance, etha-
nolic radix extract of another member of the Stellaria genus (Stel-
laria dichotoma) improved glucose homeostasis in high-fat-diet fed
mice.28 In contrast, Chidrawar et al. found that ethanolic extract of
Stellaria media was ineffective to decrease hyperglycaemia in both
cafeteria-diet- and progesterone-induced obesity models.29,30
However, they also found that 200 and 400 mg/kg methanolic
extract significantly attenuated serum glucose levels in these
models.29,30 These controversial results may be explained by the
differences in (i) the composition of the extracts, (ii) delivery time,
administration and dose of Stellaria media, (iii) the applied animal
models and strains. It should be also noted that intraperitoneal
application of ethanolic and methanolic extracts of Stellaria media
has limited translational value in the view of the human con-
sumption of this medicinal plant.
Diabetic cardiomyopathy is one of the major consequences of
diabetes. In our study, aortic flow, cardiac output and cardiac work
were significantly decreased in the Diabetes group in comparison
to the Control group, showing that this experimental diabetes
model has some adverse effects on the heart. Stellaria media tea
treatment significantly improved cardiac output and cardiac work,
suggesting that Stellaria media tea may have beneficial effects on
the heart in a diabetic state. To the best of our knowledge, in the
literature currently there is no other experimental data concerning
the effects of Stellaria media on cardiac function or cardiomyopathy.
Our research group tested the effects of Stellaria media tea lyophi-
lizate in another chronic metabolic disease, i.e. hyper-
cholesterolaemia, where we demonstrated that the treatment has
no blood cholesterol lowering effect in diet-induced hyper-
cholesterolaemia in rats.31 In the same study, we investigated some
safety issues of the Stellaria media treatment on the heart. Our
transthoracic echocardiographic measurements showed that Stel-
laria media treatment did not affect cardiac morphology and pa-
rameters related to cardiac function in diet-induced
hypercholesterolaemia.31
Various mechanisms may play a role in the development of8
cardiac dysfunction in diabetes, e.g. oxidative stress, diffuse
apoptosis of cardiomyocytes, dysregulation of cardiac signaling
pathways, mitochondrial dysfunction, fibrosis or hypertrophy.26,32
Interestingly, there are more than 50 medicinal herbs, such as
sesame,33 which have beneficial effects on experimental diabetic
cardiomyopathy (for review please see Refs. 32,34). These plants
have been suggested to exert antioxidant properties that may
attenuate oxidative stress or inflammation, and to reduce
apoptosis, and cardiac remodelling.32 In the literature, there are
some experimental data suggesting similar antioxidant and anti-
inflammatory properties of Stellaria media, which can be associ-
ated with the improvement of certain cardiac parameters in our
present study.35 Therefore, we tested the in vitro antioxidant ca-
pacity of Stellaria media tea, and we found a low antioxidant ac-
tivity. This phenomenonwas observed by another study too, where
the antioxidant activity of the aqueous and methanolic extract was
weak.36 Stellaria media has been reported to contain active me-
tabolites e.g. phenolic compounds, flavonoids or steroid saponins,
that may play a role in pharmacological activities.35We determined
the total flavonoid content of Stellaria media tea and it was
9.88 ± 0.10 mg QE/g. The flavonoid content of Stellaria media has
been discussed by several papers.36e38 In a phytochemical study,
the flavonoid content was determined not less than 1.2% in raw
plant material.38 In an experiment, the total flavonoid content
(determined by HPLC) of a lyophilized juice was 25.6 mg/g, and in
an ethanolic extract 63.9 mg/g36. Our extract was preparedwith hot
water (in accordance with the human use) and this might explain
the lower flavonoid content. UPLC analysis of flavonoid screening
indicated rutin being a possible component in the Stellaria media
tea in our present study. The beneficial cardiovascular effect of rutin
in diabetes has been proposed. Some studies demonstrated that
rutin alleviates diabetic cardiomyopathy and improve left ventric-
ular dysfunction in STZ-induced diabetes39e42 and in high-
carbohydrate, high-fat diet models.43 Rutin was also shown to
exert neuroprotective effects whichmay be beneficial in diabetes as
well.44 LC-MS/MS analysis of the extract we used in our study
afforded identification of various glycosylated apigenin-derivatives,
which finding is in accordance with literature data.36 The glyco-
sylated flavonoid derivatives can be poorly absorbed in the in-
testines directly, therefore during digestion there is a
deglycosylation step, and after that only the aglycone part of the
molecule will be absorbed,45 therefore being responsible for the
biological effects. The aglycone part of these components is api-
genin, which has already been reported to alleviate STZ-induced
diabetic cardiomyopathy46 and to exert protective effects against
cardiac dysfunction in myocardial infarction in diabetic rats,47
suggesting that apigenin-derivatives may contribute to the bene-
ficial cardiac effects of Stellaria media tea.
The limited antioxidant capacity of the water extract raised the
question whether signaling pathways are involved in the cardiac
effects. Based on literature data, STAT3 is proposed as a key medi-
ator of diabetes-induced cardiac dysfunction.48e50 In conjunction
with other studies51e53 (for specific review please see Ref. 54), we
showed that diabetes increased cardiac STAT3 phosphorylation.
Moreover, Stellaria media tea treatment prevented diabetes-
induced cardiac STAT3 dysregulation, suggesting a protective role.
Indeed, some studies demonstrated that attenuation of the
enhanced cardiac STAT3 activation may be beneficial in diabetes. In
a high-glucose, high-fat diet and STZ injection-induced diabetic rat
model, losartan attenuated the cardiac STAT3 phosphorylation and
improved heart function.53 In STZ-induced diabetic mice hearts,
inhibition of diabetes-induced activation of EGFR-STAT3 signaling
was associated with restoring cardiac fibrosis and hypertrophy
related factors, and prevented diabetes-induced cardiac dysfunc-
tion.50 Interestingly, the possible presence of rutin in Stellaria media
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study, as rutin was suggested to exert cytoprotection by inhibiting
STAT3 phosphorylation.55,56 Similarly, apigenin and its derivatives
has been shown to attenuate STAT3 activation in tumor cells,57,58
which is in agreement with our present findings observed in car-
diac tissue and may be related to the beneficial effect of Stellaria
media tea on diabetic cardiomyopathy.
Nevertheless, a better understanding of the molecular mecha-
nism underlying the proposed beneficial cardiac effects of Stellaria
media tea would require additional research in the future. Further
investigation of STAT3 signaling pathway could identify down-
stream targets or direct cause-effect mechanisms. Applying other
doses of the tea, using a different extraction method or combina-
tion with standard therapies may also contribute to a deeper
knowledge. Testing the effects of the tea in female rats could reveal
sex differences in the effectiveness of the extract. It would beworth
studying the effects of Stellaria media tea not only in a rat model,
but in humans as well whether we can observe functional cardiac
improvement in diabetic patients who drink chickweed tea
regularly.
Although we provide interesting data on the effects of Stellaria
media in diabetes, as always, there may be some possible limita-
tions of our present study. The animals received Stellaria media tea
from the onset of the experiments, together with the fructose-
enriched diet. It would be worthwhile testing its effects in a
developed diabetic state, which may have greater clinical rele-
vance. Moreover, elucidation of the causal relation between the
tea's beneficial effect and STAT3 phosphorylationwith state-of-the-
art experiments or further analysis of downstream targets in dia-
betic cardiomyopathy would be straightforward in the future. We
tested the effects in a rat model, which might differ from the hu-
man metabolism. Moreover, the lack of a group receiving only
herbal treatment without fructose-enriched diet can also be
considered as a possible limitation.
In conclusion, the tea made of Stellaria media (i.e. common
chickweed) may protect against diabetes-induced cardiac
dysfunction; however, this effect seems to be independent of the
modulation of fasting hyperglycemia or glucose tolerance in rats.
Stellaria media prevented diabetes induced STAT3 phosphorylation
in the heart, which may play a role in the beneficial cardiac effect.
Nevertheless, further studies are needed to reveal the exact mo-
lecular mechanisms underlying the proposed cardioprotective ef-
fect of Stellaria media in diabetic conditions.
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